Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04713449 · ClinicalTrials.gov registry record · NA

Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial

A NA study of Head and Neck Cancer and Oropharyngeal Cancer, sponsored by Rutgers, The State University of New Jersey.

Active
Registry status
NA
Development phase
643
Enrollment target
1
Study location

NCT04713449: Active NA study of Head and Neck Cancer and Oropharyngeal Cancer, sponsored by Rutgers, The State University of New Jersey.

NCT04713449 is a NA study of Head and Neck Cancer and Oropharyngeal Cancer that is active but no longer recruiting, run by Rutgers, The State University of New Jersey. The registered enrollment target is 643 participants, above the 258-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (149% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04713449, a NA study of Head and Neck Cancer and Oropharyngeal Cancer, is active but no longer recruiting, sponsored by Rutgers, The State University of New Jersey.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
643 participants
Enrollment target
1
Study location

Study Summary

Project's goal is evaluate an online tool the research team created called Empowered Survivor (ES) against a free online self-management intervention developed for cancer survivors by the National Cancer Institute and the American Cancer Society called Springboard Beyond Cancer.

Primary Outcome

Change in self- efficacy measured with the Self-efficacy scale (22 items) which targets confidence in managing aspects of self-care (e.g., dry mouth, swallowing, oral self-exam, communicating with providers, emotions). Administered at multiple time points to measure effect of the intervention. Ratings range from 1 (not at all confident) to 5 (very confident). An item average will be calculated.

Interventions

  • OTHER Survey Administration
  • OTHER Empowered Survivor Online
  • OTHER Springboard Beyond Cancer

Study Locations (1)

New Jersey

  • Rutgers Cancer Institute of New Jersey - New Brunswick

Trial Details

FieldValue
Enrollment Target 643 participants
Start Date 2021-01-19
Est. Completion 2027-02-28
Phase NA

What the registry record for NCT04713449 still lists

NCT04713449 is an interventional study that assigns participants to a tested intervention. The registered 643 participants enrollment target is mid-sized for trials with a published cap, above the 258-participant average among 250 other Head and Neck Cancer trials with a reported enrollment target (149% higher).

The record links to 3 conditions, with Head and Neck Cancer appearing as the primary indexed condition, and to 3 interventions - of which Survey Administration is the first listed.

NCT04713449 reports a single indexed study location in New Jersey.

Frequently Asked Questions

What is clinical trial NCT04713449 about?

NCT04713449 is a clinical study titled "Enhancing Self Care Among Oral Cancer Survivors: The Empowered Survival Trial". Project's goal is evaluate an online tool the research team created called Empowered Survivor (ES) against a free online self-management intervention developed for cancer survivors by the National Cancer Institute and the American Cancer Society called Springboard Beyond Cancer.

What is the current status of trial NCT04713449?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 643 participants. The study started on 2021-01-19. Estimated completion is 2027-02-28.

What conditions does trial NCT04713449 study?

This clinical trial studies the following conditions: Head and Neck Cancer, Oropharyngeal Cancer, Oral Cancer.

What interventions are being tested in trial NCT04713449?

The interventions under investigation include: Survey Administration (OTHER), Empowered Survivor Online (OTHER), Springboard Beyond Cancer (OTHER).

Who is sponsoring clinical trial NCT04713449?

This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04713449 being conducted?

This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Head and Neck Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04713449's enrollment target sits among peer trials

643 19th of 250 higher than 232 of 250 other Head and Neck Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Head and Neck Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05146297 · 644 participants · NA

    Diversity and Inclusion in Research Underpinning Prevention and Therapy Trials

  • NCT06994442 · 644 participants · Phase 3

    Optimizing Pain Treatment in Children On Mechanical Ventilation

  • NCT05204888 · 642 participants · NA

    myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

  • NCT07012395 · 645 participants · Phase 2

    A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04713449, the US trial registry maintained by the National Library of Medicine. NCT04713449 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.